150 related articles for article (PubMed ID: 34936169)
1. Incidence and risk of cancer among multiple sclerosis patients: A matched population-based cohort study.
Bosco-Lévy P; Foch C; Grelaud A; Sabidó M; Lacueille C; Jové J; Boutmy E; Blin P
Eur J Neurol; 2022 Apr; 29(4):1091-1099. PubMed ID: 34936169
[TBL] [Abstract][Full Text] [Related]
2. Incidence of malignancies in patients with multiple sclerosis versus a healthy matched cohort: A population-based cohort study in the Netherlands using the PHARMO Database Network.
Kuiper JG; Overbeek JA; Foch C; Boutmy E; Sabidó M
J Clin Neurosci; 2022 Sep; 103():49-55. PubMed ID: 35810606
[TBL] [Abstract][Full Text] [Related]
3. Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study.
Sun LM; Lin CL; Chung CJ; Liang JA; Sung FC; Kao CH
Eur J Neurol; 2014 Feb; 21(2):238-44. PubMed ID: 24053223
[TBL] [Abstract][Full Text] [Related]
4. Risk of cancer among Finnish multiple sclerosis patients.
Hongell K; Kurki S; Sumelahti ML; Soilu-Hänninen M
Mult Scler Relat Disord; 2019 Oct; 35():221-227. PubMed ID: 31404761
[TBL] [Abstract][Full Text] [Related]
5. A population-based cohort study suggests an increased risk of multiple sclerosis incidence in patients with type 2 diabetes mellitus.
Hou WH; Li CY; Chang HH; Sun Y; Tsai CC
J Epidemiol; 2017 May; 27(5):235-241. PubMed ID: 28142047
[TBL] [Abstract][Full Text] [Related]
6. Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study.
Marrie RA; Maxwell C; Mahar A; Ekuma O; McClintock C; Seitz D; Webber C; Groome PA
Neurology; 2021 Jan; 96(4):e501-e512. PubMed ID: 33239364
[TBL] [Abstract][Full Text] [Related]
7. Risk of dementia in older veterans with multiple sclerosis.
Fleming NH; Bahorik A; Xia F; Yaffe K
Mult Scler Relat Disord; 2024 Feb; 82():105372. PubMed ID: 38104510
[TBL] [Abstract][Full Text] [Related]
8. Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.
Grytten N; Myhr KM; Celius EG; Benjaminsen E; Kampman M; Midgard R; Vatne A; Aarseth JH; Riise T; Torkildsen Ø
Mult Scler; 2020 Oct; 26(12):1569-1580. PubMed ID: 31573834
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study.
Grytten N; Myhr KM; Celius EG; Benjaminsen E; Kampman MT; Midgard R; Vatne A; Aarseth JH; Riise T; Torkildsen Ø
Mult Scler Relat Disord; 2021 Oct; 55():103209. PubMed ID: 34419754
[TBL] [Abstract][Full Text] [Related]
10. Cancer related mortality in multiple sclerosis. A population based cohort study.
Grytten N; Myhr KM; Celius EG; Benjaminsen E; Midgard R; Vatne A; Aarseth JH; Mannseth J; Torkildsen Ø
Mult Scler Relat Disord; 2023 Jan; 69():104417. PubMed ID: 36423459
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
12. Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Tseng CC; Chang SJ; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Yen JH
Prev Med; 2016 Mar; 84():6-11. PubMed ID: 26724518
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of multiple sclerosis after traumatic brain injury: a nationwide population-based study.
Kang JH; Lin HC
J Neurotrauma; 2012 Jan; 29(1):90-5. PubMed ID: 22044110
[TBL] [Abstract][Full Text] [Related]
14. Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study.
Zecca C; Disanto G; Sacco R; MacLachlan S; Kuhle J; Ramagopalan SV; Gobbi C
J Neurol; 2021 Mar; 268(3):817-824. PubMed ID: 33084939
[TBL] [Abstract][Full Text] [Related]
15. Epilepsy in multiple sclerosis: A nationwide population-based register study.
Burman J; Zelano J
Neurology; 2017 Dec; 89(24):2462-2468. PubMed ID: 29117950
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence and prevalence of psoriasis in multiple sclerosis.
Marrie RA; Patten SB; Tremlett H; Wolfson C; Leung S; Fisk JD
Mult Scler Relat Disord; 2017 Apr; 13():81-86. PubMed ID: 28427708
[TBL] [Abstract][Full Text] [Related]
17. Cancer risk in multiple sclerosis: findings from British Columbia, Canada.
Kingwell E; Bajdik C; Phillips N; Zhu F; Oger J; Hashimoto S; Tremlett H
Brain; 2012 Oct; 135(Pt 10):2973-9. PubMed ID: 22730559
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
[TBL] [Abstract][Full Text] [Related]
19. Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients.
Alping P; Askling J; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
Ann Neurol; 2020 May; 87(5):688-699. PubMed ID: 32056253
[TBL] [Abstract][Full Text] [Related]
20. Herpes Zoster and Subsequent Cancer Risk: A Nationwide Population-Based Cohort Study in Korea.
Kim M; Han K; Yoo SA; Lee JH
Dermatology; 2021; 237(1):73-78. PubMed ID: 32114571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
